Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: When do the ends justify the means?

Laryngoscope

Volumn 110, Issue 3 II, 2000, Pages 1-18

  Goodwin Jr , W Jarrard ^a,b  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Head and neck cancer; Performance status; Quality of life; Recurrence; Salvage surgery

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; GASTROINTESTINAL TUMOR; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT CANCER; REVIEW; SALVAGE THERAPY; SOCIOECONOMICS; SQUAMOUS CELL CARCINOMA; TERMINAL CARE; UPPER GASTROINTESTINAL TRACT;

EID: 0343550388     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200003001-00001     Document Type: Review

References (64)

1. Jesse RH, Sugarbaker EV. Squamous cell carcinoma of oropharynx: why we fail. Am J Surg 1976;132:435-438.
2. Shah JP, Cendon RA, Farr HW, Strong EW. Carcinoma of the oral cavity. Am J Surg 1976;132:504-507.
3. Gilbert H, Kagan AR. Recurrence patterns in squamous cell carcinoma of the oral cavity, pharynx, and larynx. J Surg Oncol 1974:357-380.
4. Stell PM. Time to recurrence of squamous cell carcinoma of the head neck. Head Neck 1991;13:277-281.
5. Relman AS. Assessment and accountability: the third revolution in medical care. N Engl J Med 1988;319:1220-1222.
6. Glass GV, McGraw B, Smith ML. Meta-analysis in Clinical Trials. Beverly Hills, CA: Sage Publications, 1981.
7. Simon R. Meta-Analysis and Cancer Clinical Trials. Principles and Practice of Oncology 1991;5(6):1-10.
8. Pittam MR, Thornton H, Palmer V, Chapman P, Shaw HJ. Results and prognostic factors in salvage surgery for squamous carcinomas of the tongue. Br J Surg 1982;69: 188-190.
9. Razack M, Sako K, Patel JK. The role of initial modality in treatment of squamous cell carcinoma of the tongue. J Surg Oncol 1982;19:136-138.
10. Fitzpatrick PJ, Tepperman BS. Carcinoma of the floor of the mouth. J Assoc Can Radiol 1982;33:148-153.
11. Decroix Y, Ghossein N. Experience of the Curie Institute in treatment of cancer of the mobile tongue. Cancer 1981;47: 496-502.
12. Mulholland MW, Megallanes F, Press BHJ, Shons AR, McQuarrie DG. Aggressive surgical therapy after irradiation failure in treatment of cancer of the oral tongue. Arch Surg 1984;119:394-399.
13. Pradhan SA, Rajpal RM, Kothary PM. Surgical management of postradiation residual/recurrent cancer of the base of the tongue. J Surg Oncol 1980;14:201-206.
14. Parsons JT, Million RR, Cassisi NJ. Carcinoma of the base of the tongue: results of radical irradiation with surgery reserved for irradiation failure. Laryngoscope 1982;92: 689-696.
15. Sultan MR, Coleman JJ. Oncologic and functional considerations of total glossectomy. Am J Surg 1989;158:297-302.
16. Viani L, Dammeijer P, Jones AS, Dalby JE, Stell PM. Recurrence of oropharyngeal carcinoma after radiotherapy. J Laryngol Otol 1991;105:24-28.
17. Regueiro CA, de la Torre A, Valcarcel FJ, Magallon R, Aragon G. Salvage brachytherapy and salvage surgery for recurrent oropharyngeal carcinoma following radiotherapy. J Laryngol Otol 1995;109(1):45-48.
18. Wong CS, Ang KK, Fletcher GH, et al. Definitive radiotherapy for squamous cell carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys 1989;16:657-662.
19. Pacheco-Ojeda L, Marandas P, Julieron M, Lusinchi A, Mamelle G, Luboinski B. Salvage surgery by composite resection for epidermoid carcinoma of the tonsillar region. Arch Otolaryngol Head Neck Surg 1992;118:181-184.
20. Gehanno P, Depondt J, Guedon C, Kebaili C, Koka V. Primary and salvage surgery for cancer of the tonsillar region: a retrospective study of 120 patients. Head Neck 1993;15: 185-189.
21. Yuen APW, Ignace, Ho CM. Results of surgical salvage for radiation failures of laryngeal carcinoma. Otolaryngol Head Neck Surg 1995;112(3):405-409.
22. Shaw HJ. A view of partial laryngectomy in the treatment of laryngeal cancer. J Laryngol Otol 1987;101:143-154.
23. Fisher AJ, Caldarelli DD, Chacko DC, Holinger LD. Glottic cancer. Arch Otolaryngol Head Neck Surg 1986;112: 519-521.
24. Rothfield RE, Johnson JT, Myers EN, Wagner RL. The role of hemilaryngectomy in the management of t1 vocal cord cancer. Arch Otolaryngol Head Neck Surg 1989;115: 677-680.
25. Nichols RD, Mickelson SA. Partial laryngectomy after irradiation failure. Ann Otol Rhinol Laryngol 1991;100:76-80.
26. Strauss M. Hemilaryngectomy rescue surgery for radiation failure in early glottic carcinoma. Laryngoscope 1988;98: 317-320.
27. Nibu K, Kamata S, Kawabata K, Nakamizo M, Nigauri T, Hoki K. Partial laryngectomy in the treatment of radiation-failure of early glottic carcinoma. Head Neck 1997;19:116-120.
28. Jose B, Calhoun DL, Mohamed A. Recurrences after irradiation in early vocal cord cancers with literature review. J Surg Oncol 1984;27:224-227.
29. Maipang T, Razack MS, Sako K, Chen TY. Surgical salvage for recurrent "early" glottic cancers. J Surg Oncol 1989;40: 32-33.
30. Suzuki H, Hasegawa T, Sano R, Kim Y. Results of treatment of laryngeal cancer. Acta Otolaryngol (Stockh) 1994;511: 186-191.
31. Croll GA, Gerritsen GJ, Tiwari RM, Snow GB. Primary radiotherapy with surgery in reserve for advanced laryngeal carcinoma: results and complications. Eur J Surg Oncol 1989;15:350-356.
32. Foote RL, Olsen KD, Kunselman SJ, et al. Early-stage squamous cell carcinoma of the glottic larynx managed with radiation therapy. Mayo Clin Proc 1992;67:629-636.
33. DelGaudio JM, Fleming DJ, Esclamado RM, Carroll WR, Bradford CR. Hemilaryngectomy for glottic carcinoma after radiation therapy failure. Arch Otolaryngol Head Neck Surg 1994;120:959-963.
34. Lavey RS, Calcaterra TC. Partial laryngectomy for glottic cancer after high-dose radiotherapy. Am J Surg 1991;162: 341-344.
35. Fleming WB, Long TM. Results of the surgical treatment of selected patients with squamous cell cancer of the mouth and throat. Aust N Z J Surg 1978;48(6):610-612.
36. Meyz JW, Towpik E. Surgical and cryosurgical salvage of oral and oropharyngeal cancer recurring after radical radiotherapy. Eur J Surg Oncol 1991;17:567-570.
37. Jones AS, Hanafi ZB, Nadapalan V, Roland NJ, Kinsella A, Helliwell TR. Do positive resection margins after ablative surgery for head neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery. Br J Cancer 1996; 74(1):128-132.
38. Davidson J, Briant D, Gullane P, Keane T, Rawlinson E. The role of surgery following radiotherapy failure for advanced laryngopharyngeal cancer Arch Otolaryngol Head Neck Surg 1994;120:269-276.
39. Mendenhall WM, Parsons JT, Amdur RJ, Cassisi NJ, Million RR. Squamous cell carcinoma of the head neck treated with radiotherapy: does planned neck dissection reduce the chance for successful surgical management of subsequent local recurrence? Head Neck Surg 1988:302-304.
40. Schipper H, Clinch J, McMurray, et al. Measuring the quality of life of cancer patients: the functional living index-cancer - development and validation. J Clin Oncol 1984; 2(5):472-483.
41. List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head neck cancer patients. Cancer 1990;66: 564-569.
42. SAS Institute, Inc. SAS User's Guide: Statistics, version 6, Cary, NC: SAS Institute, Inc., 1992.
43. Parmar MK, Machin D. Survival Analysis: A Practical Approach. New York: Wiley, 1995.
44. Sherman AC, Simonton-Atchley S. Psychological Aspects of Treating Oncology Patients. In: Myers and Suen, Cancer of the Head Neck. edn 3. Philadelphia: WB Saunders, 1996: 917-925.
45. List MA, Butler P, Vokes EE, et al. Head Neck Cancer (HNC) Patients: How do Patients Prioritize Potential Treatment Outcomes. Abstract 1472. American Society for Clinical Oncology, Los Angeles, CA, May 16-19, 1998.
46. Levendag PC, Meeuwis CA, Visser AG. Reirradiation of recurrent head neck cancers: external and/or interstitial radiation therapy. Radiother Oncol 1992;23:6-15.
47. Stevens KR, Britsch A, Moss WT. High-dose reirradiation of head neck cancer with curative intent. Int J Radiat Oncol Biol Phys 1994;29(4):687-698.
48. Wang CC. To irradiate or not to irradiate? Int J Radiat Oncol Biol Phys 1994;29(4):913.
49. Armand JP, Cvitkovic E, Recondo G, et al. Salvage chemotherapy in recurrent head neck cancer: The Institut Gustav Roussy experience. Am J Otolaryngol 1993;14(5): 301-306.
50. Forastiere AA. Overview of platinum chemotherapy in head neck cancer. Semin Oncol 1994;21(5):20-27.
51. Amrein JP. Current chemotherapy of head neck cancer. J Oral Maxillofac Surg 1991;49:864-870.
52. Pinto HA, Jacobs C. Chemotherapy for recurrent and metastatic head neck cancer. Hematol Oncol Clin North Am 1991;5(4):667-685.
53. Recondo G, Armand JP, Tellez-Bernal E, et al. Recurrent and/or metastatic head neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy. Laryngoscope 1991;101:494-501.
54. Constenla DO, Hill ME, A'Hern RP, et al. Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neck. Ann Oncol 1997;8(5):445-449.
55. Hussain M, Salwen W, Kuck O, et al. Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head neck: a preliminary report. Semin Oncol 1997;24(6-19):S19-43-45.
56. Shin DM, Glisson BS, Khuri FR, et al. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head neck Semin Oncol 1997;24(6-19):S19-33-37.
57. Cortesina G, De Stefani A, Galeazzi E., et al. Temporary regression of recurrent squamous cell carcinoma of the head neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically. Br J Cancer 1994;69(3):572-576.
58. Kitahara S, Ikeda M, Inouye T, et al. Inhibition of head neck metastatic and/or recurrent cancer by local administration of multi-cytokine inducer OK-432. J Laryngol Otol 1996; 110(5):449-453.
59. Clayman GL, El-Naggar AK, Lippman S, et al. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head neck squamous cell carcinoma. J Clin Oncol 1998;16(6):2221-2232.
60. Tan EH, Adelstein DJ, Saxton JP, et al. Concurrent chemoradiotherapy for salvage in relapsed squamous cell head neck cancer. Cancer Invest 1997;15(5):422-428.
61. American Cancer Society. Cancer Facts and Figures, special edition. American Cancer Society, 1997,3-7.
62. Huang AT, Cole TB, Fishburn R, Jelovsek SB. Adjuvant chemotherapy after surgery and radiation for stage III and IV head neck cancer. Ann Surg 1983;200(2):195-199.
63. Rate WR, Garrett P, Hamaker R, et al. Intraoperative radiation therapy for recurrent head and neck cancer. Cancer 1991;67:2738-2740.
64. Park RI, Liverman FZ, Lee DJ, Goldsmith MM, Price JC. Iodine-125 seed implantation as an adjunct to surgery in advanced recurrent squamous cell cancer of the head neck. Laryngoscope 1991;101:405-410.